Novo Nordisk Invests Billions in Buybacks While Expanding Heart-Disease Evidence
Novo Nordisk repurchases DKK 4.47bn in shares amid 38% stock drop, unveils POSEIDON study on residual inflammatory risk,…
Novo Nordisk Invests $500M in Irish Factory and Preps Oral Wegovy for Europe as Profit Pressures Per
Novo Nordisk pours $500M into Irish plant, signaling oral Wegovy’s blockbuster potential beyond US. European rollout imminent as…